livazo tablets film-coated
recordati industria chimica e farmaceutica s.p.a. - pitavastatin (pitavastatin calcium) - tablets film-coated - 4mg
urorec capsules hard
recordati industria chimica e farmaceutica s.p.a. - silodosin - capsules hard - 8mg
urorec capsules hard
recordati industria chimica e farmaceutica s.p.a. - silodosin - capsules hard - 4mg
urorec capsules hard
recordati industria chimica e farmaceutica s.p.a. - silodosin - capsules hard - 8mg
peganone- ethotoin tablet
recordati rare diseases, inc. - ethotoin (unii: 46qg38nc4u) (ethotoin - unii:46qg38nc4u) - ethotoin 250 mg - peganone (ethotoin tablets, usp) is indicated for the control of tonic-clonic (grand mal) and complex partial (psychomotor) seizures. peganone (ethotoin tablets, usp) is contraindicated in patients with hepatic abnormalities or hematologic disorders.
desoxyn- methamphetamine hydrochloride tablet
recordati rare diseases, inc. - methamphetamine hydrochloride (unii: 997f43z9cv) (methamphetamine - unii:44ral3456c) - methamphetamine hydrochloride 5 mg - attention deficit disorder with hyperactivity: desoxyn tablets are indicated as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children over 6 years of age with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate to severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. the diagnosis of this syndrome should not be made with finality when these symptoms are only of comparatively recent origin. nonlocalizing (soft) neurological signs, learning disability, and abnormal eeg may or may not be present, and a diagnosis of central nervous system dysfunction may or may not be warranted. in patients known to be hypersensitive to amphetamine, or other components of desoxyn. hypersensitivity reactions such as angioedema and anaphylactic reactions have been reported in patients treated with other amphetamine p
sylvant
pharmacy retailing (nz) ltd t/a healthcare logistics - siltuximab 100mg; ; - powder for infusion concentrate - 100 mg - active: siltuximab 100mg excipient: histidine polysorbate 80 sucrose - sylvant is indicated for the treatment of adult patients with multicentric castleman's disease (mcd) who are human immunodeficiency virus (hiv) negative and human herpesvirus-8 (hhv-8) negative.
sylvant
pharmacy retailing (nz) ltd t/a healthcare logistics - siltuximab 400mg; ; - powder for infusion concentrate - 400 mg - active: siltuximab 400mg excipient: histidine polysorbate 80 sucrose - sylvant is indicated for the treatment of adult patients with multicentric castleman's disease (mcd) who are human immunodeficiency virus (hiv) negative and human herpesvirus-8 (hhv-8) negative.
qarziba dinutuximab beta 4.5 mg/ml concentrate for solution for infusion, 20 mg/4.5 ml vial
recordati rare diseases australia pty ltd - dinutuximab beta, quantity: 4.5 mg/ml - solution - excipient ingredients: polysorbate 20; hydrochloric acid; sucrose; water for injections; histidine - qarziba is indicated for the treatment of high-risk neuroblastoma in patients who have previously received induction chemotherapy and achieved at least a partial response.
zanidip
viatris limited - lercanidipine hydrochloride 10mg; - film coated tablet - 10 mg - active: lercanidipine hydrochloride 10mg excipient: hypromellose iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate povidone powdered cellulose purified talc sodium starch glycolate titanium dioxide - zanidip is indicated for the treatment of mild to moderate hypertension.